1. Home
  2. MYGN vs THRM Comparison

MYGN vs THRM Comparison

Compare MYGN & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.00

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$28.43

Market Cap

844.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
THRM
Founded
1991
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
844.7M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
MYGN
THRM
Price
$5.00
$28.43
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$7.64
$38.60
AVG Volume (30 Days)
1.3M
190.3K
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.59
Revenue
$771,400,000.00
$554,979,000.00
Revenue This Year
$6.89
$4.90
Revenue Next Year
$5.35
$7.19
P/E Ratio
N/A
$48.43
Revenue Growth
2.33
50.16
52 Week Low
$3.76
$23.67
52 Week High
$8.59
$39.48

Technical Indicators

Market Signals
Indicator
MYGN
THRM
Relative Strength Index (RSI) 56.21 44.32
Support Level $4.23 $27.02
Resistance Level $5.67 $29.37
Average True Range (ATR) 0.29 0.79
MACD 0.07 0.22
Stochastic Oscillator 70.69 50.56

Price Performance

Historical Comparison
MYGN
THRM

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Share on Social Networks: